G9776 HCPCS code: Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)
G9776 is the HCPCS Level II code for documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason). Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case.
Code details
| Field | Value |
|---|---|
| Section | G codes — Procedures and professional services (temporary) |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | Z2 |
| Added | 2017-01-01 |
| Last action effective | 2017-01-01 |
What changed for G9776
- 2017-01-01: G9776 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code G9776?
G9776 is the HCPCS Level II code for documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason). Short descriptor: "Doc med rsn no proph antiem".
Does Medicare cover G9776?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related G97 codes
- G9700 — Patients who use hospice services any time during the measurement period
- G9701 — Children who are taking antibiotics in the 30 days prior to the date of the encounter during which the diagnosis was established
- G9702 — Patients who use hospice services any time during the measurement period
- G9703 — Episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date
- G9704 — Ajcc breast cancer stage i: t1 mic or t1a documented
- G9705 — Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented
- G9706 — Low (or very low) risk of recurrence, prostate cancer
- G9707 — Patient received hospice services any time during the measurement period
- G9708 — Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy
- G9709 — Hospice services used by patient any time during the measurement period
- G9710 — Patient was provided hospice services any time during the measurement period
- G9711 — Patients with a diagnosis or past history of total colectomy or colorectal cancer
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under G9776
- Watch G9776 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for G9776
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.